A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...

The first of two new University of Kansas Cancer Center clinics is wrapping up construction and readying to open in two weeks ...

New AI-driven applications launch seemingly every day, offering endless possibilities. AI can transform our immense body of medical knowledge into tangible outcomes for patients and healthcare ...

EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for ...

Quadrants has released its latest Gold Nanoparticles Startups/SMEs Companies Assessment, 2025, recognizing key players, including both global giants and emerging innovators, for their excellence in ...

The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which incl ...

The National Comprehensive Cancer Network® (NCCN®) has recognized several individuals and contributors with its 2025 awards, celebrating their remarkable commitment to quality, equitable, and ...